2012
DOI: 10.1517/17425247.2012.694863
|View full text |Cite
|
Sign up to set email alerts
|

Clinical translation of folate receptor-targeted therapeutics

Abstract: Each of the two strategies has advantages and disadvantages. Identification of the best target patient population is likely critical to the ultimate success of FR-targeted agents in the clinic. A successful clinical strategy may require the integration between FR expression analysis and an optimal combination of FR-targeted therapy and standard chemotherapy. Advancement into Phase III trials and the ongoing clinical development of several additional folate conjugates are likely to usher in a new era of clinica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
45
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(45 citation statements)
references
References 59 publications
0
45
0
Order By: Relevance
“…Folate is a basic component of cell metabolism and DNA synthesis and repair. Cancer cells, which rapidly divide, have an increased requirement for folate to maintain DNA synthesis, an observation supported by the widespread use of antifolates in cancer chemotherapy [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…Folate is a basic component of cell metabolism and DNA synthesis and repair. Cancer cells, which rapidly divide, have an increased requirement for folate to maintain DNA synthesis, an observation supported by the widespread use of antifolates in cancer chemotherapy [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…Farletuzumab is a fully humanized antibody derived from the murine antibody LK26, which binds FRα to promote cell lysis by both complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity [Farrell et al 2012;Jelovac and Armstrong, 2012;Teng et al 2012]. In addition, the binding of farletuzumab to FRα also suppresses the proliferation and growth of FRα-expressing cells and tumors by preventing the phosphorylation of substrates specific for Lyn kinase [Jelovac and Armstrong, 2012].…”
Section: Targeting the Frα In Tumorsmentioning
confidence: 99%
“…99m Tc-etarfolatide takes advantage of the more optimal SPECT imaging characteristics of technetium (half-life of 6 h and 140-keV photon) and has been evaluated in several clinical trials (1,3,11,13,16).…”
Section: M Tc-etarfolatide Characteristicsmentioning
confidence: 99%
“…Folate is a water-soluble B vitamin that is essential for cellular processes such as nucleotide biosynthesis (1). Cellular folate transport can be mediated by folate receptors (FRs), of which the a and b subtypes are the most studied (2).…”
mentioning
confidence: 99%